Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms

A technology of Bifidobacterium longum and a composition, applied in the field of probiotics, can solve problems such as uncertainty as to whether depression is the main cause, and achieve the effects of prolonging antidepressant effect, preventing depression symptoms, and improving safety

Pending Publication Date: 2018-08-03
SOC DES PROD NESTLE SA
View PDF8 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Examples of "depressive disorder not otherwise specified" include premenstrual dysphoric disorder, mild depressive disorder, recurrent short-term depressive disorder, and where a clinician has diagnosed a depressive disorder but cannot identify a depressive disorder due to a general medical condition or substance trigger Whether it is the main cause of the situation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms
  • Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms
  • Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0103] The following non-limiting examples are randomized, double-blind, placebo-controlled trials showing that Bifidobacterium longum ATCC BAA-999 improves depressive symptoms.

[0104] introduce : Specific probiotics improve bowel symptoms in IBS, however, their efficacy in treating comorbid symptoms of anxiety or depression in this population is unknown. Bifidobacterium longum ATCC BAA-999 has previously been shown to normalize hippocampal neurotrophic factor levels in murine models of anxiety-like behavior and low-grade gut inflammation. The inventors also have unpublished data on a mouse model of depression, also showing improved sleep patterns in mice.

[0105] goals and methods : In order to evaluate the effect of Bifidobacterium longum ATCC BAA-999 on anxiety and depressive symptoms in IBS patients and to investigate the underlying mechanism, the present inventors studied IBS patients with diarrhea or mixed stool pattern (Rome III criteria) and mild to moderate anxie...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; "empty" feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating,or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms thatdo not respond to treatment; and combinations thereof. These depressive symptoms can be associated with a depressive state or depressive disorder or can be found sub-clinically or not associated withthese depressive states / disorders (e.g., not part of a syndrome or psychiatric disorder).

Description

Background technique [0001] This disclosure generally relates to probiotics. In particular, compositions and methods for treating or preventing depressive symptoms using Bifidobacterium longum NCC3001 (ATCC BAA-999) are disclosed. [0002] Depression (both physical and emotional) has a significant negative impact on quality of life. Depression is associated with impaired neurotransmission such as low neurotransmitter levels. Accordingly, compounds that increase the levels of neurotransmitters in the brain and thus facilitate their transmission exhibit antidepressant properties as well as beneficial effects on a variety of other psychiatric disorders. The major neurotransmitters are serotonin, dopamine, norepinephrine, norepinephrine, acetylcholine, glutamate, gamma-amino-butyric acid, and neuropeptides. Enhanced neurotransmission is achieved by increasing the concentration of neurotransmitter in the synaptic cleft, thus making neurotransmitter available to enhance or prolon...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/745A61P25/24
CPCA61K35/745A61P25/24A23L33/135A23V2002/00A23V2200/3202A23V2200/3204A23V2200/322
Inventor G·贝尔贡泽利德贡达T·阿尔维斯努内斯V·马夸特J·A·J·施密特
Owner SOC DES PROD NESTLE SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products